Influence of Rosiglitazone on Mucus Hypersecretion in Rat Airway Epithelium

刘维佳,李万成,文富强,刘代顺,李艳萍,冯玉麟
DOI: https://doi.org/10.3969/j.issn.1671-6205.2006.06.014
2006-01-01
Abstract:Objective To investigate the influence and mechanism of rosiglitazone,an agonist of peroxisome proliferators activated receptor gamma(PPAR-γ),on mucus hypersecretion in rat airway.Methods 36 male SD rats were randomly divided into 6 groups,ie. a control group(group A),a rosiglitazone group(group B),a mucus hypersecretion group(group C),a low dosage group of rosiglitazone(group D),a moderate dosage group of rosiglitazone(group E),a high dosage group of rosiglitazone(group F).The levels of tumor necrosis factor-α(TNF-α),interleukin-1β(IL-1β) and IL-8 in bronchoalveolar lavage fluid(BALF) were detected by ELISA.The expressions of MUC5AC and mucin in bronchial tissues were examined by histochemical analysis and alcian blue-periodic acid schiff(AB-PAS) staining,respectively.Results The overexpressions of MUC5AC,mucin and the increased levels of TNF-α,IL-1β,IL-8 were detected in groups C,D,E and F compared to group A(P0.01 or P0.05).In groups D,E and F,the expressions of MUC5AC,mucin and the levels of TNF-α, IL-1β ,IL-8 were gradually decreased(P0.01 or P0.05).The decreases were obvious in groups E and F compared to group C.The increased levels of TNF-α,IL-1β,and IL-8 in BALF were well correlated with the overexpression of MUC5AC and mucin(r=0.827,0.795,0.924,0.805,0.812,0.917,respectively,P0.01 or P0.05) in the mucus hypersecretion group.Conclusion Rosiglitazone can decrease the expressions of TNF-α,IL-8 and suppress mucus hypersecretion in rat airway.
What problem does this paper attempt to address?